Health&Life Co EBITDA per Employee
The EBITDA per Employee of Health&Life Co (1781.TWO) as of Oct 8, 2026 is -165,415.00 TWD. In the previous year, EBITDA per Employee was 74,295.00 TWD — a change of -322.65% (lower).
Get this data via API
Financial Data API
EBITDA per Employee
-165,415.00TWD
YoY
-322.65%
Last updated:
The Health&Life Co EBITDA per Employee history
3 Years
10 Years
25 Years
Max
| YEAR | EBITDA per Employee | YoY |
|---|---|---|
| -165,415.00TWD | -322.65% | |
| 74,295.00TWD | -174.28% | |
| -100,017.50TWD | -11.26% | |
| -112,702.50TWD | -53.47% | |
| -242,230.00TWD | +477.49% | |
| -41,945.00TWD | -78.59% | |
| -195,910.00TWD | +37.35% | |
| -142,635.00TWD | -13.35% | |
| -164,612.50TWD | -15.82% | |
| -195,542.50TWD | -10.47% | |
| -218,417.50TWD | -2.39% | |
| -223,757.50TWD | — |
Health&Life Co Stock analysis
Frequently Asked Questions about Health&Life Co stock
EBITDA per Employee of Health&Life Co is -165,415.00 TWD in 2025.
EBITDA per Employee of Health&Life Co changed from 74,295.00 TWD to -165,415.00 TWD, representing a -322.65% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBITDA per Employee Health&Life Co since 2006 – with annual values, charts, and detailed analysis.
EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.
EBITDA per Employee's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Health&Life Co historically and in real time.
Workforce — Health&Life Co
All Key Metrics — Health&Life Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth